Hebei General Hospital

Futó vizsgálatok

• Még nem toboroz

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

  NCT07447986· 2. fázis· Hangzhou Sumgen Biotech Co., Ltd.· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

  NCT07110415· 4. fázis· SPH Qingdao Growful Pharmacetical Co.,Ltd· Forrás

• Még nem toboroz

  The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

  NCT07139587· Qingxia Li· Forrás

• Még nem toboroz

  A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

  NCT06958861· 2. fázis· Shanghai Huilun Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  NCT06641466· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  NCT06806293· 3. fázis· AbbVie· Forrás

• Még nem toboroz

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás

• Fut, nem toboroz

  Sympathetic Mapping/ Ablation of Renal Nerves Trial

  NCT02761811· SyMap Medical (Suzhou), Ltd.· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Koszorúér-betegség2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Bronchiectasis1 toboroz
• Elhízás1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Lupus (SLE)1 toboroz
• Migrén1 toboroz
• Stroke (szélütés)1 toboroz

Lezárt vizsgálatok

• Lezárult

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

  NCT05810038· 3. fázis· Pfizer· Forrás

• Lezárult

  Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

  NCT05417841· Beijing Hospital· Forrás

• Lezárult

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· 3. fázis· Tasly Biopharmaceuticals Co., Ltd.· Forrás

• Lezárult

  Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

  NCT05546320· 2. fázis· Chinese Academy of Medical Sciences, Fuwai Hospital· Forrás

• Lezárult

  A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

  NCT05371652· 3. fázis· Pfizer· Forrás

• Lezárult

  Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

  NCT04944706· 2. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás

• Lezárult

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· 3. fázis· Novo Nordisk A/S· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Migrén19 munka · 6 vizsgálat
• Uterine fibroids9 munka · 0 vizsgálat
• Trigeminal neuralgia4 munka · 0 vizsgálat